H.C. Wainwright Assumes NRx Pharmaceuticals (NRXP) at Buy, 'A Paradigm Shift in the Treatment of Depression With Suicidality'

September 8, 2025 6:52 AM EDT Send to a Friend
(Updated - September 8, 2025 7:01 AM EDT)

H.C. Wainwright analyst Patrick Trucchio assumes coverage on NRx Pharmaceuticals (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login